デフォルト表紙
市場調査レポート
商品コード
1760560

COVID-19用かっ香正气(Huoxiang Zhengqi)の世界市場レポート 2025年

Huoxiang Zhengqi For Covid 19 Global Market Report 2025


出版日
ページ情報
英文 175 Pages
納期
2~10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.89円
COVID-19用かっ香正气(Huoxiang Zhengqi)の世界市場レポート 2025年
出版日: 2025年07月01日
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

COVID-19用かっ香正气(Huoxiang Zhengqi)の市場規模は今後数年で急成長が見込まれます。2029年にはCAGR12.4%で24億8,000万米ドルに成長します。予測期間に予測される成長は、免疫健康サプリメントの人気の高まり、軽微な健康問題に対するセルフメディケーションの傾向の高まり、非医薬品的介入に対する需要の高まり、伝統的な漢方薬製品をオンラインで入手しやすくなったこと、個別化された健康ソリューションに対する需要の高まりに起因しています。予測期間に予想される主な動向には、技術支援による遠隔診断、新しい剤形の開発、相乗効果のある製剤の創出、遠隔医療プラットフォームへの統合、病院のCOVID-19治療ガイドラインとの整合などがあります。

伝統的な漢方薬に対する需要の高まりが、Huoxiang Zhengqi for COVID-19市場の成長を促進すると予想されます。伝統的な中国医学(TCM)は古代の治療システムであり、漢方薬、鍼治療、マッサージ、食事療法を利用して身体のエネルギーバランスを整え、治癒を促進し、病気を予防します。TCMの需要が増加しているのは、消費者が代替療法を求め、自然療法やホリスティックな健康法への関心が高まっていることが主因です。Huoxiang Zhengqi for COVID-19は、免疫系のバランスを整え、ウイルス感染に伴う症状を緩和する能力で知られるハーブ成分を統合した治療ソリューションを提供することで、TCMを強化します。例えば、2025年1月、国立医学図書館は、薬用材料や植物エキスを含む中国伝統医学の輸出額が2023年に19億3,300万米ドルに達したと報告しました。その結果、伝統的な漢方薬の需要の増加が、COVID-19用かっ香正气(Huoxiang Zhengqi)市場の成長を牽引しています。

漢方薬の需要の増加も、COVID-19用かっ香正气(Huoxiang Zhengqi)市場の成長を促進すると予想されています。漢方薬は、植物または植物由来物質を治療目的で使用し、健康状態を予防、治療、管理するものです。漢方薬への嗜好が高まっているのは、主に消費者の自然療法への関心によるもので、これらの代替品は合成薬に比べて安全で、副作用が少なく、その他の健康特典があると認識されているからです。COVID-19のHuoxiang Zhengqiは、免疫機能を高め、症状を緩和し、回復を促進する伝統的な治療薬を提供することで漢方薬をサポートし、ウイルス感染症の管理における漢方治療の役割を示しています。例えば、2024年9月、HerbalGramは、ハーブ栄養補助食品の年間売上高が4.4%成長し、2022年の120億1,800万㌦から2023年には125億5,100万㌦に増加すると報告しました。その結果、漢方薬の需要増がHuoxiang Zhengqi for COVID-19市場の成長に拍車をかけています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界のCOVID-19用かっ香正气(Huoxiang Zhengqi )PESTEL分析(政治、社会、技術、環境、法的要因、促進要因と抑制要因)
  • 最終用途産業の分析
  • 世界のCOVID-19用かっ香正气(Huoxiang Zhengqi)市場:成長率分析
  • 世界のCOVID-19用かっ香正气(Huoxiang Zhengqi)市場の実績:規模と成長、2019年~2024年
  • 世界のCOVID-19用かっ香正气(Huoxiang Zhengqi)市場の予測:規模と成長、2024年~2029年、2034年
  • 世界のCOVID-19用かっ香正气(Huoxiang Zhengqi)総アドレス可能市場(TAM)

第6章 市場セグメンテーション

  • 世界のCOVID-19用かっ香正气(Huoxiang Zhengqi)市場:製品タイプ別、実績と予測、2019年~2024年、2024年~2029年、2034年
  • 液体
  • 錠剤
  • 顆粒
  • その他の製品タイプ
  • 世界のCOVID-19用かっ香正气(Huoxiang Zhengqi)市場:消費者別、実績と予測、2019年~2024年、2024年~2029年、2034年
  • 健康志向の消費者
  • 免疫サポートを求める人々
  • 代替医療愛好家
  • 子どものために購入する親
  • 世界のCOVID-19用かっ香正气(Huoxiang Zhengqi)市場:使用場面別、実績と予測、2019年~2024年、2024年~2029年、2034年
  • 予防医療用途
  • COVID-19の症状が出ている間
  • 回復後の健康管理
  • 季節性疾患予防
  • 世界のCOVID-19用かっ香正气(Huoxiang Zhengqi)市場:用途別、実績と予測、2019年~2024年、2024年~2029年、2034年
  • 病院
  • クリニック
  • ホームケア
  • その他の用途
  • 世界のCOVID-19用かっ香正气(Huoxiang Zhengqi)市場:流通チャネル別、実績と予測、2019年~2024年、2024年~2029年、2034年
  • オンライン薬局
  • 小売薬局
  • 病院薬局
  • その他の流通チャネル
  • 世界のCOVID-19用かっ香正气(Huoxiang Zhengqi)市場、液体の種類別サブセグメンテーション、実績と予測、2019年~2024年、2024年~2029年、2034年
  • 経口液
  • 注射液
  • 世界のCOVID-19用かっ香正气(Huoxiang Zhengqi)市場、錠剤の種類別サブセグメンテーション、実績と予測、2019年~2024年、2024年~2029年、2034年
  • タブレット
  • カプセル
  • 世界のCOVID-19用かっ香正气(Huoxiang Zhengqi)市場、顆粒の種類別サブセグメンテーション、実績と予測、2019年~2024年、2024年~2029年、2034年
  • 単回投与顆粒
  • 多回投与顆粒
  • 世界のCOVID-19用かっ香正气(Huoxiang Zhengqi)市場、その他の製品タイプのサブセグメンテーション、タイプ別、実績と予測、2019年~2024年、2024年~2029年、2034年
  • シロップ
  • 溶液用粉末

第7章 地域別・国別分析

  • 世界のCOVID-19用かっ香正气(Huoxiang Zhengqi)市場:地域別、実績と予測、2019年~2024年、2024年~2029年、2034年
  • 世界のCOVID-19用かっ香正气(Huoxiang Zhengqi)市場:国別、実績と予測、2019年~2024年、2024年~2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • COVID-19用かっ香正气(Huoxiang Zhengqi)市場:競合情勢
  • COVID-19用かっ香正气(Huoxiang Zhengqi)市場:企業プロファイル
    • Yunnan Baiyao Group Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Beijing Tongrentang Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Taiji Group Chongqing Fuling Pharmaceutical Factory Co. Ltd Overview, Products and Services, Strategy and Financial Analysis
    • Zhangzhou Pientzehuang Pharmaceutical Co. Ltd Overview, Products and Services, Strategy and Financial Analysis
    • Tasly Pharmaceutical Group Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • Harbin Pharmaceutical Group Co. Ltd.
  • Guizhou Sanli Pharmaceutical Co. Ltd
  • China Shineway Pharmaceutical Group Limited
  • Hubei University of Chinese Medicine
  • Beijing University of Chinese Medicine
  • Wuhu Zhanghengchun Medicine Co. Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • COVID-19用かっ香正气(Huoxiang Zhengqi)市場2029年:新たな機会を提供する国
  • COVID-19用かっ香正气(Huoxiang Zhengqi)市場2029年:新たな機会を提供するセグメント
  • COVID-19用かっ香正气(Huoxiang Zhengqi)市場2029年:成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r35437

Huoxiang Zhengqi for COVID-19 is a traditional Chinese herbal formula used to treat COVID-19 cases, particularly when gastrointestinal symptoms such as nausea, diarrhea, or fatigue due to dampness are present. The primary aim in this context is to expel dampness, relieve exterior syndromes, and support digestive and immune functions. It is often combined with antiviral and supportive therapies as part of traditional Chinese medicine protocols.

The primary product forms of Huoxiang Zhengqi for COVID-19 include liquid, pills, granules, and other variants. The liquid form of Huoxiang Zhengqi is a traditional herbal remedy designed to alleviate digestive issues such as nausea, vomiting, and bloating by balancing the stomach and spleen. Its typical consumers include health-conscious individuals, those seeking immune system support, alternative medicine supporters, and parents purchasing for their children. It is commonly used for preventive health, managing COVID-19 symptoms, post-recovery health management, as well as for seasonal and illness-related protection. It is suitable for use in hospitals, clinics, home care settings, and other environments, with applications across hospitals, clinics, home care, and additional settings.

The huoxiang zhengqi for COVID-19 market research report is one of a series of new reports from The Business Research Company that provides huoxiang zhengqi for COVID-19 market statistics, including the huoxiang zhengqi for COVID-19 industry's global market size, regional shares, competitors with the huoxiang zhengqi for COVID-19 market share, detailed huoxiang zhengqi for COVID-19 market segments, market trends and opportunities, and any further data you may need to thrive in the huoxiang zhengqi for COVID-19 market. This huoxiang zhengqi for COVID-19 market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The huoxiang zhengqi for COVID-19 market size has grown rapidly in recent years. It will grow from $1.38 billion in 2024 to $1.55 billion in 2025 at a compound annual growth rate (CAGR) of 12.8%. The growth during the historic period can be attributed to the increasing demand for traditional Chinese medicine, growing public awareness of natural remedies, rising cases of gastrointestinal symptoms, a higher demand for immune-boosting products, and a surge in COVID-19 cases.

The huoxiang zhengqi for COVID-19 market size is expected to see rapid growth in the next few years. It will grow to $2.48 billion in 2029 at a compound annual growth rate (CAGR) of 12.4%. The growth projected for the forecast period can be attributed to the rising popularity of immune health supplements, the growing trend of self-medication for minor health issues, an increasing demand for non-pharmaceutical interventions, greater accessibility of traditional Chinese medicine products online, and a rising demand for personalized health solutions. Key trends expected in the forecast period include technology-assisted remote diagnosis, the development of new dosage forms, the creation of synergistic formulations, integration into telehealth platforms, and alignment with hospital COVID-19 treatment guidelines.

The rising demand for traditional Chinese medicines is expected to drive the growth of the Huoxiang Zhengqi for COVID-19 market. Traditional Chinese medicine (TCM) is an ancient healing system that utilizes herbal remedies, acupuncture, massage, and dietary therapy to balance the body's energy, promote healing, and prevent illness. The increasing demand for TCM is primarily driven by growing interest in natural and holistic health approaches, as consumers seek alternative remedies. Huoxiang Zhengqi for COVID-19 enhances TCM by offering a therapeutic solution that integrates herbal ingredients known for their ability to balance the immune system and alleviate symptoms associated with viral infections. For instance, in January 2025, the National Library of Medicine reported that the export value of traditional Chinese medicine, including medicinal materials and plant extracts, reached \$1.933 billion in 2023. As a result, the growing demand for traditional Chinese medicines is driving the growth of the Huoxiang Zhengqi for COVID-19 market.

The increasing demand for herbal medicine is also expected to propel the growth of the Huoxiang Zhengqi for COVID-19 market. Herbal medicine involves using plants or plant-derived substances for therapeutic purposes to prevent, treat, or manage health conditions. The rising preference for herbal medicine is mainly driven by consumers' interest in natural remedies, as they perceive these alternatives to be safer, with fewer side effects and additional health benefits compared to synthetic drugs. Huoxiang Zhengqi for COVID-19 supports herbal medicine by providing a traditional remedy that boosts immune function, alleviates symptoms, and promotes recovery, showing the role of herbal therapies in managing viral infections. For instance, in September 2024, the HerbalGram reported a 4.4% growth in annual sales of herbal dietary supplements, increasing from \$12.018 billion in 2022 to \$12.551 billion in 2023. Consequently, the growing demand for herbal medicine is fueling the growth of the Huoxiang Zhengqi for COVID-19 market.

The rising incidence of respiratory diseases is expected to drive further growth in the Huoxiang Zhengqi for COVID-19 market. Respiratory diseases are conditions that affect the lungs and respiratory system, often leading to breathing difficulties and impaired lung function. The rise in respiratory diseases is primarily due to increasing air pollution, which exposes individuals to harmful pollutants that irritate the airways and worsen lung health. Huoxiang Zhengqi for COVID-19 aids in treating respiratory diseases by addressing symptoms linked to dampness and digestive imbalances, which are common in respiratory infections. It supports recovery by alleviating nausea, chest congestion, and fatigue, enhancing resilience during mild respiratory illnesses. For instance, in April 2024, the Australian Bureau of Statistics reported a rise in deaths due to acute respiratory infections, with 361 deaths in 2023 compared to 241 in 2022. Thus, the increasing incidence of respiratory diseases is further fueling the growth of the Huoxiang Zhengqi for COVID-19 market.

Major players in the huoxiang zhengqi for covid 19 market are Yunnan Baiyao Group Co. Ltd., Beijing Tongrentang Co. Ltd., Taiji Group Chongqing Fuling Pharmaceutical Factory Co. Ltd, Zhangzhou Pientzehuang Pharmaceutical Co. Ltd, Tasly Pharmaceutical Group Co. Ltd., Harbin Pharmaceutical Group Co. Ltd., Guizhou Sanli Pharmaceutical Co. Ltd, China Shineway Pharmaceutical Group Limited, Hubei University of Chinese Medicine, Beijing University of Chinese Medicine, Wuhu Zhanghengchun Medicine Co. Ltd.

Asia-Pacific was the largest region in the Huoxiang Zhengqi for COVID-19 market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in huoxiang Zhengqi for COVID-19 report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the huoxiang Zhengqi for COVID-19 market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The huoxiang Zhengqi for COVID-19 market consists of sales of syrups, powders, injections, essential oils, and nasal sprays. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Huoxiang Zhengqi For Covid 19 Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on huoxiang zhengqi for covid 19 market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for huoxiang zhengqi for covid 19 ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The huoxiang zhengqi for covid 19 market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Liquid; Pills; Granules; Other Product Types
  • 2) By Consumers: Health-Conscious Consumers; Individuals Seeking Immunity Support; Alternative Medicine Enthusiasts; Parents Purchasing For Children
  • 3) By Usage Occasions: Preventive Health Use; During COVID 19 Symptoms; Post-Recovery Health Management; Seasonal Illness Protection
  • 4) By Application: Hospitals; Clinics; Home Care; Other Applications

5) By Distribution Chanel; Online Pharmacies; Retail Pharmacies; Hospital Pharmacies; Other Distribution Chanels

  • Subsegments:
  • 1) By Liquid: Oral Liquid; Injectable Liquid
  • 2) By Pills: Tablets; Capsules
  • 3) By Granules: Single-Dose Granules; Multi-Dose Granules
  • 4) By Other Product Types: Syrup; Powder For Solution
  • Companies Mentioned: Yunnan Baiyao Group Co. Ltd.; Beijing Tongrentang Co. Ltd.; Taiji Group Chongqing Fuling Pharmaceutical Factory Co. Ltd; Zhangzhou Pientzehuang Pharmaceutical Co. Ltd; Tasly Pharmaceutical Group Co. Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Huoxiang Zhengqi For Covid 19 Market Characteristics

3. Huoxiang Zhengqi For Covid 19 Market Trends And Strategies

4. Huoxiang Zhengqi For Covid 19 Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Huoxiang Zhengqi For Covid 19 Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Huoxiang Zhengqi For Covid 19 PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Huoxiang Zhengqi For Covid 19 Market Growth Rate Analysis
  • 5.4. Global Huoxiang Zhengqi For Covid 19 Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Huoxiang Zhengqi For Covid 19 Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Huoxiang Zhengqi For Covid 19 Total Addressable Market (TAM)

6. Huoxiang Zhengqi For Covid 19 Market Segmentation

  • 6.1. Global Huoxiang Zhengqi For Covid 19 Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Liquid
  • Pills
  • Granules
  • Other Product Types
  • 6.2. Global Huoxiang Zhengqi For Covid 19 Market, Segmentation By Consumers, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Health-Conscious Consumers
  • Individuals Seeking Immunity Support
  • Alternative Medicine Enthusiasts
  • Parents Purchasing For Children
  • 6.3. Global Huoxiang Zhengqi For Covid 19 Market, Segmentation By Usage Occasions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Preventive Health Use
  • During COVID 19 Symptoms
  • Post-Recovery Health Management
  • Seasonal Illness Protection
  • 6.4. Global Huoxiang Zhengqi For Covid 19 Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinics
  • Home Care
  • Other Applications
  • 6.5. Global Huoxiang Zhengqi For Covid 19 Market, Segmentation By Distribution Chanel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Online Pharmacies
  • Retail Pharmacies
  • Hospital Pharmacies
  • Other Distribution Chanels
  • 6.6. Global Huoxiang Zhengqi For Covid 19 Market, Sub-Segmentation Of Liquid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oral Liquid
  • Injectable Liquid
  • 6.7. Global Huoxiang Zhengqi For Covid 19 Market, Sub-Segmentation Of Pills, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Tablets
  • Capsules
  • 6.8. Global Huoxiang Zhengqi For Covid 19 Market, Sub-Segmentation Of Granules, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Dose Granules
  • Multi-Dose Granules
  • 6.9. Global Huoxiang Zhengqi For Covid 19 Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Syrup
  • Powder For Solution

7. Huoxiang Zhengqi For Covid 19 Market Regional And Country Analysis

  • 7.1. Global Huoxiang Zhengqi For Covid 19 Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Huoxiang Zhengqi For Covid 19 Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Huoxiang Zhengqi For Covid 19 Market

  • 8.1. Asia-Pacific Huoxiang Zhengqi For Covid 19 Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Huoxiang Zhengqi For Covid 19 Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Huoxiang Zhengqi For Covid 19 Market, Segmentation By Consumers, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Huoxiang Zhengqi For Covid 19 Market, Segmentation By Usage Occasions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Huoxiang Zhengqi For Covid 19 Market

  • 9.1. China Huoxiang Zhengqi For Covid 19 Market Overview
  • 9.2. China Huoxiang Zhengqi For Covid 19 Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Huoxiang Zhengqi For Covid 19 Market, Segmentation By Consumers, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Huoxiang Zhengqi For Covid 19 Market, Segmentation By Usage Occasions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Huoxiang Zhengqi For Covid 19 Market

  • 10.1. India Huoxiang Zhengqi For Covid 19 Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Huoxiang Zhengqi For Covid 19 Market, Segmentation By Consumers, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Huoxiang Zhengqi For Covid 19 Market, Segmentation By Usage Occasions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Huoxiang Zhengqi For Covid 19 Market

  • 11.1. Japan Huoxiang Zhengqi For Covid 19 Market Overview
  • 11.2. Japan Huoxiang Zhengqi For Covid 19 Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Huoxiang Zhengqi For Covid 19 Market, Segmentation By Consumers, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Huoxiang Zhengqi For Covid 19 Market, Segmentation By Usage Occasions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Huoxiang Zhengqi For Covid 19 Market

  • 12.1. Australia Huoxiang Zhengqi For Covid 19 Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Huoxiang Zhengqi For Covid 19 Market, Segmentation By Consumers, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Huoxiang Zhengqi For Covid 19 Market, Segmentation By Usage Occasions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Huoxiang Zhengqi For Covid 19 Market

  • 13.1. Indonesia Huoxiang Zhengqi For Covid 19 Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Huoxiang Zhengqi For Covid 19 Market, Segmentation By Consumers, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Huoxiang Zhengqi For Covid 19 Market, Segmentation By Usage Occasions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Huoxiang Zhengqi For Covid 19 Market

  • 14.1. South Korea Huoxiang Zhengqi For Covid 19 Market Overview
  • 14.2. South Korea Huoxiang Zhengqi For Covid 19 Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Huoxiang Zhengqi For Covid 19 Market, Segmentation By Consumers, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Huoxiang Zhengqi For Covid 19 Market, Segmentation By Usage Occasions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Huoxiang Zhengqi For Covid 19 Market

  • 15.1. Western Europe Huoxiang Zhengqi For Covid 19 Market Overview
  • 15.2. Western Europe Huoxiang Zhengqi For Covid 19 Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Huoxiang Zhengqi For Covid 19 Market, Segmentation By Consumers, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Huoxiang Zhengqi For Covid 19 Market, Segmentation By Usage Occasions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Huoxiang Zhengqi For Covid 19 Market

  • 16.1. UK Huoxiang Zhengqi For Covid 19 Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Huoxiang Zhengqi For Covid 19 Market, Segmentation By Consumers, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Huoxiang Zhengqi For Covid 19 Market, Segmentation By Usage Occasions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Huoxiang Zhengqi For Covid 19 Market

  • 17.1. Germany Huoxiang Zhengqi For Covid 19 Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Huoxiang Zhengqi For Covid 19 Market, Segmentation By Consumers, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Huoxiang Zhengqi For Covid 19 Market, Segmentation By Usage Occasions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Huoxiang Zhengqi For Covid 19 Market

  • 18.1. France Huoxiang Zhengqi For Covid 19 Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Huoxiang Zhengqi For Covid 19 Market, Segmentation By Consumers, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Huoxiang Zhengqi For Covid 19 Market, Segmentation By Usage Occasions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Huoxiang Zhengqi For Covid 19 Market

  • 19.1. Italy Huoxiang Zhengqi For Covid 19 Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Huoxiang Zhengqi For Covid 19 Market, Segmentation By Consumers, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Huoxiang Zhengqi For Covid 19 Market, Segmentation By Usage Occasions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Huoxiang Zhengqi For Covid 19 Market

  • 20.1. Spain Huoxiang Zhengqi For Covid 19 Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Huoxiang Zhengqi For Covid 19 Market, Segmentation By Consumers, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Huoxiang Zhengqi For Covid 19 Market, Segmentation By Usage Occasions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Huoxiang Zhengqi For Covid 19 Market

  • 21.1. Eastern Europe Huoxiang Zhengqi For Covid 19 Market Overview
  • 21.2. Eastern Europe Huoxiang Zhengqi For Covid 19 Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Huoxiang Zhengqi For Covid 19 Market, Segmentation By Consumers, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Huoxiang Zhengqi For Covid 19 Market, Segmentation By Usage Occasions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Huoxiang Zhengqi For Covid 19 Market

  • 22.1. Russia Huoxiang Zhengqi For Covid 19 Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Huoxiang Zhengqi For Covid 19 Market, Segmentation By Consumers, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Huoxiang Zhengqi For Covid 19 Market, Segmentation By Usage Occasions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Huoxiang Zhengqi For Covid 19 Market

  • 23.1. North America Huoxiang Zhengqi For Covid 19 Market Overview
  • 23.2. North America Huoxiang Zhengqi For Covid 19 Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Huoxiang Zhengqi For Covid 19 Market, Segmentation By Consumers, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Huoxiang Zhengqi For Covid 19 Market, Segmentation By Usage Occasions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Huoxiang Zhengqi For Covid 19 Market

  • 24.1. USA Huoxiang Zhengqi For Covid 19 Market Overview
  • 24.2. USA Huoxiang Zhengqi For Covid 19 Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Huoxiang Zhengqi For Covid 19 Market, Segmentation By Consumers, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Huoxiang Zhengqi For Covid 19 Market, Segmentation By Usage Occasions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Huoxiang Zhengqi For Covid 19 Market

  • 25.1. Canada Huoxiang Zhengqi For Covid 19 Market Overview
  • 25.2. Canada Huoxiang Zhengqi For Covid 19 Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Huoxiang Zhengqi For Covid 19 Market, Segmentation By Consumers, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Huoxiang Zhengqi For Covid 19 Market, Segmentation By Usage Occasions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Huoxiang Zhengqi For Covid 19 Market

  • 26.1. South America Huoxiang Zhengqi For Covid 19 Market Overview
  • 26.2. South America Huoxiang Zhengqi For Covid 19 Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Huoxiang Zhengqi For Covid 19 Market, Segmentation By Consumers, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Huoxiang Zhengqi For Covid 19 Market, Segmentation By Usage Occasions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Huoxiang Zhengqi For Covid 19 Market

  • 27.1. Brazil Huoxiang Zhengqi For Covid 19 Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Huoxiang Zhengqi For Covid 19 Market, Segmentation By Consumers, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Huoxiang Zhengqi For Covid 19 Market, Segmentation By Usage Occasions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Huoxiang Zhengqi For Covid 19 Market

  • 28.1. Middle East Huoxiang Zhengqi For Covid 19 Market Overview
  • 28.2. Middle East Huoxiang Zhengqi For Covid 19 Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Huoxiang Zhengqi For Covid 19 Market, Segmentation By Consumers, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Huoxiang Zhengqi For Covid 19 Market, Segmentation By Usage Occasions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Huoxiang Zhengqi For Covid 19 Market

  • 29.1. Africa Huoxiang Zhengqi For Covid 19 Market Overview
  • 29.2. Africa Huoxiang Zhengqi For Covid 19 Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Huoxiang Zhengqi For Covid 19 Market, Segmentation By Consumers, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Huoxiang Zhengqi For Covid 19 Market, Segmentation By Usage Occasions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Huoxiang Zhengqi For Covid 19 Market Competitive Landscape And Company Profiles

  • 30.1. Huoxiang Zhengqi For Covid 19 Market Competitive Landscape
  • 30.2. Huoxiang Zhengqi For Covid 19 Market Company Profiles
    • 30.2.1. Yunnan Baiyao Group Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Beijing Tongrentang Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Taiji Group Chongqing Fuling Pharmaceutical Factory Co. Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Zhangzhou Pientzehuang Pharmaceutical Co. Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Tasly Pharmaceutical Group Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Huoxiang Zhengqi For Covid 19 Market Other Major And Innovative Companies

  • 31.1. Harbin Pharmaceutical Group Co. Ltd.
  • 31.2. Guizhou Sanli Pharmaceutical Co. Ltd
  • 31.3. China Shineway Pharmaceutical Group Limited
  • 31.4. Hubei University of Chinese Medicine
  • 31.5. Beijing University of Chinese Medicine
  • 31.6. Wuhu Zhanghengchun Medicine Co. Ltd.

32. Global Huoxiang Zhengqi For Covid 19 Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Huoxiang Zhengqi For Covid 19 Market

34. Recent Developments In The Huoxiang Zhengqi For Covid 19 Market

35. Huoxiang Zhengqi For Covid 19 Market High Potential Countries, Segments and Strategies

  • 35.1 Huoxiang Zhengqi For Covid 19 Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Huoxiang Zhengqi For Covid 19 Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Huoxiang Zhengqi For Covid 19 Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer